{"items": "50", "sentiment_score_definition": "x <= -0.35: Bearish; -0.35 < x <= -0.15: Somewhat-Bearish; -0.15 < x < 0.15: Neutral; 0.15 <= x < 0.35: Somewhat_Bullish; x >= 0.35: Bullish", "relevance_score_definition": "0 < x <= 1, with a higher score indicating higher relevance.", "feed": [{"title": "Amazon-backed Anthropic launches iPhone app and business tier to compete with OpenAI's ChatGPT", "url": "https://www.cnbc.com/2024/05/01/anthropic-iphone-ai-app-business-plan-to-compete-with-openai-announced.html", "time_published": "20240501T150001", "authors": ["Hayden Field"], "summary": "Anthropic on Wednesday announced its first-ever enterprise offering, as well as its first iOS app.", "banner_image": "https://image.cnbcfm.com/api/v1/image/107320283-1697736965856-gettyimages-1734163998-omarques_19102023_TECHPOL-1.jpeg?v=1714573631&w=1920&h=1080", "source": "CNBC", "category_within_source": "Top News", "source_domain": "www.cnbc.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.333333"}, {"topic": "Manufacturing", "relevance_score": "0.333333"}, {"topic": "Earnings", "relevance_score": "0.310843"}, {"topic": "Technology", "relevance_score": "0.333333"}], "overall_sentiment_score": 0.094987, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "ASAN", "relevance_score": "0.07913", "ticker_sentiment_score": "0.001028", "ticker_sentiment_label": "Neutral"}, {"ticker": "GOOG", "relevance_score": "0.039614", "ticker_sentiment_score": "0.124395", "ticker_sentiment_label": "Neutral"}, {"ticker": "NVDA", "relevance_score": "0.07913", "ticker_sentiment_score": "-0.010255", "ticker_sentiment_label": "Neutral"}, {"ticker": "PINS", "relevance_score": "0.039614", "ticker_sentiment_score": "0.112583", "ticker_sentiment_label": "Neutral"}, {"ticker": "TSLA", "relevance_score": "0.039614", "ticker_sentiment_score": "0.112583", "ticker_sentiment_label": "Neutral"}, {"ticker": "PFE", "relevance_score": "0.039614", "ticker_sentiment_score": "0.000982", "ticker_sentiment_label": "Neutral"}, {"ticker": "CRYPTO:BTC", "relevance_score": "0.039614", "ticker_sentiment_score": "-0.12144", "ticker_sentiment_label": "Neutral"}]}, {"title": "What's Going With Pfizer Stock On Wednesday? - Pfizer  ( NYSE:PFE ) ", "url": "https://www.benzinga.com/general/biotech/24/05/38554240/pfizer-embraces-direct-to-consumer-model-for-covid-antiviral-says-comirnaty-revenues-continue-to-", "time_published": "20240501T143835", "authors": ["Vandana Singh"], "summary": "On Wednesday, Pfizer Inc. PFE reported first-quarter adjusted EPS of $0.82, down 33% year over year, beating the consensus of $0.54. The company witnesses a significant decrease in Comirnaty and Paxlovid revenues globally and an unfavorable impact of foreign exchange of $107 million, or 1%.", "banner_image": "https://cdn.benzinga.com/files/images/story/2024/05/01/Pfizer-shutterstock2.jpeg?width=1200&height=800&fit=crop", "source": "Benzinga", "category_within_source": "General", "source_domain": "www.benzinga.com", "topics": [{"topic": "Earnings", "relevance_score": "0.214378"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.360215"}], "overall_sentiment_score": 0.04049, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "LLY", "relevance_score": "0.254751", "ticker_sentiment_score": "0.013458", "ticker_sentiment_label": "Neutral"}, {"ticker": "PFE", "relevance_score": "0.551622", "ticker_sentiment_score": "0.149321", "ticker_sentiment_label": "Neutral"}]}, {"title": "GSK Sees Strong Demand For Vaccines and Asthma Drugs, Raises Annual Outlook - GSK  ( NYSE:GSK ) ", "url": "https://www.benzinga.com/general/biotech/24/05/38551919/gsk-sees-strong-demand-for-vaccines-and-asthma-drugs-raises-annual-outlook", "time_published": "20240501T134217", "authors": ["Vandana Singh"], "summary": "Wednesday, GSK Plc GSK reported first-quarter sales of $9.33 billion ( 7.4 billion Sterling Pounds ) , up 10% Y/Y and 13% excluding COVID. Vaccines' sales increased 16% at constant currency to 2.28 billion Pounds, reflecting U.S. demand for Arexvy and strong market growth for Shingrix in ...", "banner_image": "https://cdn.benzinga.com/files/images/story/2024/05/01/GlaxoSmithKline-building--London--2-Febr.jpeg?width=1200&height=800&fit=crop", "source": "Benzinga", "category_within_source": "General", "source_domain": "www.benzinga.com", "topics": [{"topic": "Earnings", "relevance_score": "0.538269"}, {"topic": "Life Sciences", "relevance_score": "1.0"}], "overall_sentiment_score": 0.303845, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "GSK", "relevance_score": "0.551622", "ticker_sentiment_score": "0.278662", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "PFE", "relevance_score": "0.171485", "ticker_sentiment_score": "-0.301977", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "BNTX", "relevance_score": "0.171485", "ticker_sentiment_score": "-0.301977", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "FOREX:GBP", "relevance_score": "0.086245", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}]}, {"title": "Pfizer Jumps On Hiked Guidance, Big Earnings Beat", "url": "https://www.investors.com/news/technology/pfizer-stock-pfizer-earnings-q1-2024/", "time_published": "20240501T125000", "authors": ["ALLISON GATLIN", "Investor's Business Daily"], "summary": "Pfizer Stock Jumps After Pharma Giant Raises Outlook On Big Quarterly Beat Investor's Business Daily ...", "banner_image": "https://www.investors.com/wp-content/uploads/2018/08/stock-Pfizer-03-shutter.jpg", "source": "Investors Business Daily", "category_within_source": "n/a", "source_domain": "www.investors.com", "topics": [{"topic": "Earnings", "relevance_score": "0.769861"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.684621"}], "overall_sentiment_score": 0.307318, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "PFE", "relevance_score": "0.929758", "ticker_sentiment_score": "0.506323", "ticker_sentiment_label": "Bullish"}]}, {"title": "Pfizer  ( PFE )  Q1 Earnings and Revenues Beat Estimates", "url": "https://www.zacks.com/stock/news/2265664/pfizer-pfe-q1-earnings-and-revenues-beat-estimates", "time_published": "20240501T115505", "authors": ["Zacks Equity Research"], "summary": "Pfizer (PFE) delivered earnings and revenue surprises of 46.43% and 7.37%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?", "banner_image": "https://staticx-tuner.zacks.com/images/default_article_images/default17.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Earnings", "relevance_score": "0.999981"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.266143"}], "overall_sentiment_score": 0.137221, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "PFE", "relevance_score": "0.404563", "ticker_sentiment_score": "0.146695", "ticker_sentiment_label": "Neutral"}, {"ticker": "SPRB", "relevance_score": "0.209365", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}]}, {"title": "Pfizer beats revenue estimates, raises profit outlook on cost cuts and strong non-Covid sales", "url": "https://www.cnbc.com/2024/05/01/pfizer-pfe-earnings-q1-2024.html", "time_published": "20240501T111354", "authors": ["Annika Kim Constantino"], "summary": "The results come as Pfizer tries to regain its footing after the rapid decline of its Covid business.", "banner_image": "https://image.cnbcfm.com/api/v1/image/107341902-1701439925715-gettyimages-1232570628-porzycki-pfizerph210427_npgJv.jpeg?v=1714497742&w=1920&h=1080", "source": "CNBC", "category_within_source": "Earnings", "source_domain": "www.cnbc.com", "topics": [{"topic": "Earnings", "relevance_score": "0.999491"}, {"topic": "Life Sciences", "relevance_score": "1.0"}], "overall_sentiment_score": 0.096946, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "PFE", "relevance_score": "0.697241", "ticker_sentiment_score": "-0.007776", "ticker_sentiment_label": "Neutral"}]}, {"title": "Pfizer's 44% Decline In Profits Still Tops Estimates-Stock Bounces From Decade Low", "url": "https://www.forbes.com/sites/dereksaul/2024/05/01/pfizers-44-decline-in-profits-still-tops-estimates-stock-bounces-from-decade-low/", "time_published": "20240501T110256", "authors": ["Derek Saul"], "summary": "Pfizer Earnings Beats Estimates As Stock Bounces From Decade Low Forbes ...", "banner_image": "https://imageio.forbes.com/specials-images/imageserve/6631551872290f2cebe0a12a/0x0.jpg?format=jpg&crop=4769,2684,x0,y212,safe&height=900&width=1600&fit=bounds", "source": "Forbes", "category_within_source": "n/a", "source_domain": "www.forbes.com", "topics": [{"topic": "Earnings", "relevance_score": "0.938238"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.214378"}], "overall_sentiment_score": 0.170584, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "NVO", "relevance_score": "0.169081", "ticker_sentiment_score": "0.012948", "ticker_sentiment_label": "Neutral"}, {"ticker": "PFE", "relevance_score": "0.330654", "ticker_sentiment_score": "0.110102", "ticker_sentiment_label": "Neutral"}]}, {"title": "Nasdaq, S&P 500 Futures Signal Weaker Open As Fed Decision Looms: What's Going On With Markets? - Invesco QQQ Trust, Series 1  ( NASDAQ:QQQ ) , SPDR S&P 500  ( ARCA:SPY ) ", "url": "https://www.benzinga.com/news/earnings/24/05/38544746/wall-street-set-to-open-lower-after-amd-earnings-disappoint-as-traders-look-to-feds-powell-for-reli", "time_published": "20240501T104410", "authors": ["Shanthi Rexaline"], "summary": "A negative sentiment might linger on Wall Street on Wednesday, as evidenced by stock futures, after Advanced Micro Devices, Inc.'s AMD underwhelming quarterly report, exerting pressure on the tech sector and the broader market.", "banner_image": "https://cdn.benzinga.com/files/images/story/2024/05/01/Nasdaq.jpeg?width=1200&height=800&fit=crop", "source": "Benzinga", "category_within_source": "Markets", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.142857"}, {"topic": "Energy & Transportation", "relevance_score": "0.142857"}, {"topic": "Technology", "relevance_score": "0.142857"}, {"topic": "Finance", "relevance_score": "0.142857"}, {"topic": "Economy - Monetary", "relevance_score": "0.682689"}, {"topic": "Economy - Fiscal", "relevance_score": "0.158519"}, {"topic": "Retail & Wholesale", "relevance_score": "0.142857"}, {"topic": "Financial Markets", "relevance_score": "0.996023"}, {"topic": "Manufacturing", "relevance_score": "0.142857"}, {"topic": "Earnings", "relevance_score": "0.310843"}, {"topic": "Real Estate & Construction", "relevance_score": "0.142857"}], "overall_sentiment_score": -0.012028, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "DD", "relevance_score": "0.073773", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "ALL", "relevance_score": "0.036926", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "CVS", "relevance_score": "0.073773", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "LOGI", "relevance_score": "0.073773", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "KHC", "relevance_score": "0.073773", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "NOVA", "relevance_score": "0.073773", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "UPWK", "relevance_score": "0.073773", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "MRO", "relevance_score": "0.073773", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "PFE", "relevance_score": "0.073773", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "MA", "relevance_score": "0.036926", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "NCLH", "relevance_score": "0.073773", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "NTGR", "relevance_score": "0.073773", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "AMD", "relevance_score": "0.110462", "ticker_sentiment_score": "-0.037397", "ticker_sentiment_label": "Neutral"}, {"ticker": "KLIC", "relevance_score": "0.073773", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "Z", "relevance_score": "0.036926", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "ALIZF", "relevance_score": "0.036926", "ticker_sentiment_score": "-0.02999", "ticker_sentiment_label": "Neutral"}, {"ticker": "GSK", "relevance_score": "0.073773", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "NVDA", "relevance_score": "0.073773", "ticker_sentiment_score": "-0.014478", "ticker_sentiment_label": "Neutral"}, {"ticker": "WING", "relevance_score": "0.073773", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "BLCO", "relevance_score": "0.073773", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "GRMN", "relevance_score": "0.073773", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "YUM", "relevance_score": "0.073773", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "BZH", "relevance_score": "0.073773", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "FSLR", "relevance_score": "0.073773", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "MGM", "relevance_score": "0.073773", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "EBAY", "relevance_score": "0.073773", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "ETSY", "relevance_score": "0.073773", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "ALB", "relevance_score": "0.073773", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "WOLF", "relevance_score": "0.073773", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "QRVO", "relevance_score": "0.073773", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "DVN", "relevance_score": "0.073773", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "MET", "relevance_score": "0.073773", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "CRYPTO:BTC", "relevance_score": "0.073773", "ticker_sentiment_score": "-0.202132", "ticker_sentiment_label": "Somewhat-Bearish"}]}, {"title": "Stock market today: futures drop after Starbucks and McDonald's misses", "url": "https://markets.businessinsider.com/news/stocks/stock-market-news-futures-trading-amazon-earnings-starbucks-mcdonalds-fed-2024-5", "time_published": "20240501T090300", "authors": ["Theron Mohamed"], "summary": "Stock Market News: Futures Drop After Starbucks and McDonald's Misses - Markets Insider ...", "banner_image": null, "source": "Business Insider", "category_within_source": "GoogleRSS", "source_domain": "markets.businessinsider.com", "topics": [{"topic": "Economy - Monetary", "relevance_score": "0.928139"}, {"topic": "Life Sciences", "relevance_score": "0.333333"}, {"topic": "Retail & Wholesale", "relevance_score": "0.333333"}, {"topic": "Financial Markets", "relevance_score": "0.796627"}, {"topic": "Manufacturing", "relevance_score": "0.333333"}, {"topic": "Earnings", "relevance_score": "0.988787"}], "overall_sentiment_score": 0.012192, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "TSLA", "relevance_score": "0.070517", "ticker_sentiment_score": "-0.236781", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "MA", "relevance_score": "0.070517", "ticker_sentiment_score": "0.177121", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "MDNDF", "relevance_score": "0.209365", "ticker_sentiment_score": "0.054905", "ticker_sentiment_label": "Neutral"}, {"ticker": "SBUX", "relevance_score": "0.209365", "ticker_sentiment_score": "0.127137", "ticker_sentiment_label": "Neutral"}, {"ticker": "PFE", "relevance_score": "0.070517", "ticker_sentiment_score": "0.177121", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "SWQGF", "relevance_score": "0.070517", "ticker_sentiment_score": "0.038577", "ticker_sentiment_label": "Neutral"}]}, {"title": "Investor Sentiment Falls, Dow Snaps Five-Month Win Streak - Mastercard  ( NYSE:MA ) , Coca-Cola  ( NYSE:KO ) ", "url": "https://www.benzinga.com/news/earnings/24/05/38542052/investor-sentiment-falls-dow-snaps-five-month-win-streak", "time_published": "20240501T074227", "authors": ["Avi Kapoor"], "summary": "The CNN Money Fear and Greed index showed a decline in the overall market sentiment, but the index remained in the \"Fear\" zone on Tuesday. U.S. stocks settled lower on Tuesday, with the Dow Jones index dipping more than 550 points during the session.", "banner_image": "https://cdn.benzinga.com/files/images/story/2024/05/01/Businessman-touching-stock-market-graph-.jpeg?width=1200&height=800&fit=crop", "source": "Benzinga", "category_within_source": "Trading", "source_domain": "www.benzinga.com", "topics": [{"topic": "Economy - Monetary", "relevance_score": "0.310843"}, {"topic": "Life Sciences", "relevance_score": "0.333333"}, {"topic": "Retail & Wholesale", "relevance_score": "0.333333"}, {"topic": "Financial Markets", "relevance_score": "0.108179"}, {"topic": "Manufacturing", "relevance_score": "0.333333"}, {"topic": "Earnings", "relevance_score": "0.158519"}], "overall_sentiment_score": -0.183315, "overall_sentiment_label": "Somewhat-Bearish", "ticker_sentiment": [{"ticker": "YUM", "relevance_score": "0.208464", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "KO", "relevance_score": "0.208464", "ticker_sentiment_score": "0.443308", "ticker_sentiment_label": "Bullish"}, {"ticker": "MA", "relevance_score": "0.105141", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "MDNDF", "relevance_score": "0.105141", "ticker_sentiment_score": "0.310726", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "QCOM", "relevance_score": "0.208464", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "WBD", "relevance_score": "0.105141", "ticker_sentiment_score": "-0.316184", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "MMM", "relevance_score": "0.208464", "ticker_sentiment_score": "0.443308", "ticker_sentiment_label": "Bullish"}, {"ticker": "PFE", "relevance_score": "0.208464", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "MCD", "relevance_score": "0.208464", "ticker_sentiment_score": "0.443308", "ticker_sentiment_label": "Bullish"}]}, {"title": "Amazon, Pfizer And 3 Stocks To Watch Heading Into Wednesday - Amazon.com  ( NASDAQ:AMZN ) , Pfizer  ( NYSE:PFE ) ", "url": "https://www.benzinga.com/news/earnings/24/05/38542047/amazon-pfizer-and-3-stocks-to-watch-heading-into-wednesday", "time_published": "20240501T074209", "authors": ["Avi Kapoor"], "summary": "With U.S. stock futures trading lower this morning on Wednesday, some of the stocks that may grab investor focus today are as follows: Wall Street expects Pfizer Inc. PFE to report quarterly earnings at 54 cents per share on revenue of $14.20 billion before the opening bell, according to data ...", "banner_image": "https://cdn.benzinga.com/files/images/story/2024/05/01/Amazon-logo.jpeg?width=1200&height=800&fit=crop", "source": "Benzinga", "category_within_source": "Trading", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.333333"}, {"topic": "Retail & Wholesale", "relevance_score": "0.333333"}, {"topic": "Financial Markets", "relevance_score": "0.413559"}, {"topic": "Manufacturing", "relevance_score": "0.333333"}, {"topic": "Earnings", "relevance_score": "0.997335"}], "overall_sentiment_score": 0.184964, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "YUM", "relevance_score": "0.388879", "ticker_sentiment_score": "0.09516", "ticker_sentiment_label": "Neutral"}, {"ticker": "MA", "relevance_score": "0.265378", "ticker_sentiment_score": "0.260958", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "AMZN", "relevance_score": "0.388879", "ticker_sentiment_score": "0.178314", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "PFE", "relevance_score": "0.388879", "ticker_sentiment_score": "0.389426", "ticker_sentiment_label": "Bullish"}, {"ticker": "LEG", "relevance_score": "0.388879", "ticker_sentiment_score": "-0.093455", "ticker_sentiment_label": "Neutral"}]}, {"title": "Amazon.com  ( AMZN )  Q1 2024 Earnings Call Transcript", "url": "https://www.fool.com/earnings/call-transcripts/2024/04/30/amazoncom-amzn-q1-2024-earnings-call-transcript/", "time_published": "20240501T021511", "authors": ["Motley Fool Transcribing"], "summary": "AMZN earnings call for the period ending March 31, 2024.", "banner_image": "https://g.foolcdn.com/misc-assets/fool-transcripts-logo.png", "source": "Motley Fool", "category_within_source": "n/a", "source_domain": "www.fool.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.2"}, {"topic": "Technology", "relevance_score": "0.2"}, {"topic": "Finance", "relevance_score": "0.2"}, {"topic": "Economy - Monetary", "relevance_score": "0.158519"}, {"topic": "Retail & Wholesale", "relevance_score": "0.2"}, {"topic": "Financial Markets", "relevance_score": "1.0"}, {"topic": "Manufacturing", "relevance_score": "0.2"}, {"topic": "Earnings", "relevance_score": "1.0"}], "overall_sentiment_score": 0.295784, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "NVDA", "relevance_score": "0.009838", "ticker_sentiment_score": "0.062677", "ticker_sentiment_label": "Neutral"}, {"ticker": "GTLB", "relevance_score": "0.004919", "ticker_sentiment_score": "0.065186", "ticker_sentiment_label": "Neutral"}, {"ticker": "C", "relevance_score": "0.004919", "ticker_sentiment_score": "0.088984", "ticker_sentiment_label": "Neutral"}, {"ticker": "BAC", "relevance_score": "0.004919", "ticker_sentiment_score": "0.094014", "ticker_sentiment_label": "Neutral"}, {"ticker": "MS", "relevance_score": "0.004919", "ticker_sentiment_score": "0.112706", "ticker_sentiment_label": "Neutral"}, {"ticker": "DDOG", "relevance_score": "0.004919", "ticker_sentiment_score": "0.065186", "ticker_sentiment_label": "Neutral"}, {"ticker": "SMAR", "relevance_score": "0.004919", "ticker_sentiment_score": "0.065186", "ticker_sentiment_label": "Neutral"}, {"ticker": "PFE", "relevance_score": "0.004919", "ticker_sentiment_score": "0.131778", "ticker_sentiment_label": "Neutral"}, {"ticker": "NAUBF", "relevance_score": "0.004919", "ticker_sentiment_score": "0.065186", "ticker_sentiment_label": "Neutral"}, {"ticker": "BCS", "relevance_score": "0.004919", "ticker_sentiment_score": "0.094014", "ticker_sentiment_label": "Neutral"}, {"ticker": "GDDY", "relevance_score": "0.004919", "ticker_sentiment_score": "0.065186", "ticker_sentiment_label": "Neutral"}, {"ticker": "BCOV", "relevance_score": "0.004919", "ticker_sentiment_score": "0.065186", "ticker_sentiment_label": "Neutral"}, {"ticker": "RYAOF", "relevance_score": "0.004919", "ticker_sentiment_score": "0.131778", "ticker_sentiment_label": "Neutral"}, {"ticker": "AMZN", "relevance_score": "0.088363", "ticker_sentiment_score": "0.134294", "ticker_sentiment_label": "Neutral"}, {"ticker": "NWG", "relevance_score": "0.004919", "ticker_sentiment_score": "0.143244", "ticker_sentiment_label": "Neutral"}, {"ticker": "FOREX:USD", "relevance_score": "0.004919", "ticker_sentiment_score": "0.069439", "ticker_sentiment_label": "Neutral"}]}, {"title": "BioNTech  ( BNTX )  to Report Q1 Earnings: Is a Beat in Store?", "url": "https://www.zacks.com/stock/news/2265282/biontech-bntx-to-report-q1-earnings-is-a-beat-in-store", "time_published": "20240430T155800", "authors": ["Zacks Equity Research"], "summary": "On BioNTech's (BNTX) first-quarter 2024 earnings call, investors' focus is likely to be on the updates related to its pipeline development now that the pandemic is over.", "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/98/2216.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Earnings", "relevance_score": "0.999985"}, {"topic": "Life Sciences", "relevance_score": "1.0"}], "overall_sentiment_score": 0.071326, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "ATRA", "relevance_score": "0.282234", "ticker_sentiment_score": "0.030022", "ticker_sentiment_label": "Neutral"}, {"ticker": "SRPT", "relevance_score": "0.171688", "ticker_sentiment_score": "0.167546", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "PFE", "relevance_score": "0.227538", "ticker_sentiment_score": "0.094039", "ticker_sentiment_label": "Neutral"}, {"ticker": "BNTX", "relevance_score": "0.614315", "ticker_sentiment_score": "0.061227", "ticker_sentiment_label": "Neutral"}]}, {"title": "Biodexa's Licensor Emtora to Announce Phase 2 Clinical Trial Results of eRapa\u2122 in Familial Adenomatous Polyposis to be Presented at Prestigious 2024 Digestive Disease Week Annual Meeting", "url": "https://www.globenewswire.com/news-release/2024/04/30/2872564/0/en/Biodexa-s-Licensor-Emtora-to-Announce-Phase-2-Clinical-Trial-Results-of-eRapa-in-Familial-Adenomatous-Polyposis-to-be-Presented-at-Prestigious-2024-Digestive-Disease-Week-Annual-Me.html", "time_published": "20240430T155200", "authors": ["Biodexa Pharmaceuticals PLC"], "summary": "April ...", "banner_image": "https://ml-eu.globenewswire.com/Resource/Download/8367259c-e117-4264-9988-26f7e36b032f", "source": "GlobeNewswire", "category_within_source": "n/a", "source_domain": "www.globenewswire.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.158519"}], "overall_sentiment_score": 0.07909, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "PFE", "relevance_score": "0.03878", "ticker_sentiment_score": "0.078894", "ticker_sentiment_label": "Neutral"}, {"ticker": "BDRX", "relevance_score": "0.154207", "ticker_sentiment_score": "0.001348", "ticker_sentiment_label": "Neutral"}]}, {"title": "Will These 5 Drug/Biotech Stocks Beat Q1 Earnings Forecast?", "url": "https://www.zacks.com/stock/news/2265330/will-these-5-drugbiotech-stocks-beat-q1-earnings-forecast", "time_published": "20240430T152000", "authors": ["Zacks Equity Research"], "summary": "Let's look at five large-cap pharma/biotech companies slated to release quarterly results this week.", "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/67/1932.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Earnings", "relevance_score": "1.0"}, {"topic": "Mergers & Acquisitions", "relevance_score": "0.108179"}, {"topic": "Life Sciences", "relevance_score": "1.0"}], "overall_sentiment_score": 0.158563, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "AZN", "relevance_score": "0.042953", "ticker_sentiment_score": "0.043835", "ticker_sentiment_label": "Neutral"}, {"ticker": "NVO", "relevance_score": "0.253426", "ticker_sentiment_score": "0.062112", "ticker_sentiment_label": "Neutral"}, {"ticker": "ABBV", "relevance_score": "0.042953", "ticker_sentiment_score": "0.043835", "ticker_sentiment_label": "Neutral"}, {"ticker": "MRNA", "relevance_score": "0.293841", "ticker_sentiment_score": "0.13754", "ticker_sentiment_label": "Neutral"}, {"ticker": "REGN", "relevance_score": "0.212301", "ticker_sentiment_score": "0.129453", "ticker_sentiment_label": "Neutral"}, {"ticker": "AMGN", "relevance_score": "0.293841", "ticker_sentiment_score": "0.163676", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "PFE", "relevance_score": "0.333444", "ticker_sentiment_score": "0.138141", "ticker_sentiment_label": "Neutral"}]}, {"title": "Pfizer Sees Less Revenue From Covid-19 Treatments, Stock Faces Headwinds Ahead Of Q1 Earnings - Pfizer  ( NYSE:PFE ) ", "url": "https://www.benzinga.com/analyst-ratings/analyst-color/24/04/38524922/pfizer-sees-less-revenue-from-covid-19-treatments-stock-faces-headwinds-ahead-of-q1", "time_published": "20240430T151850", "authors": ["Surbhi Jain"], "summary": "Pfizer Inc PFE stock has declined significantly due to decreased revenue from its COVID-19 products. The stock is down 34.61% over the past year, and 10.94% year-to-date. While Pfizer's dividend appears to be inexpensive, investors are noting significant risks facing the company ahead of ...", "banner_image": "https://cdn.benzinga.com/files/images/story/2024/04/30/Pfizer-shutterstock2.jpeg?width=1200&height=800&fit=crop", "source": "Benzinga", "category_within_source": "General", "source_domain": "www.benzinga.com", "topics": [{"topic": "Earnings", "relevance_score": "0.538269"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.723405"}], "overall_sentiment_score": 0.036084, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "PFE", "relevance_score": "0.701177", "ticker_sentiment_score": "0.256556", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": " ( PFE )  - Analyzing Pfizer's Short Interest - Pfizer  ( NYSE:PFE ) ", "url": "https://www.benzinga.com/insights/short-sellers/24/04/38523290/pfe-analyzing-pfizers-short-interest", "time_published": "20240430T144521", "authors": ["Benzinga Insights"], "summary": "Pfizer's PFE short percent of float has fallen 9.45% since its last report. The company recently reported that it has 65.00 million shares sold short, which is 1.15% of all regular shares that are available for trading. Based on its trading volume, it would take traders 1.94 days to cover their ...", "banner_image": "https://cdn.benzinga.com/files/images/story/2023/movers_image_0.jpeg?width=1200&height=800&fit=crop", "source": "Benzinga", "category_within_source": "Trading", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.365926"}], "overall_sentiment_score": 0.264538, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "PFE", "relevance_score": "0.212115", "ticker_sentiment_score": "0.081887", "ticker_sentiment_label": "Neutral"}]}, {"title": "Eli Lilly  ( LLY )  Tops Q1 Earnings Estimates", "url": "https://www.zacks.com/stock/news/2264689/eli-lilly-lly-tops-q1-earnings-estimates", "time_published": "20240430T115505", "authors": ["Zacks Equity Research"], "summary": "Lilly (LLY) delivered earnings and revenue surprises of 1.98% and 0.47%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?", "banner_image": "https://staticx-tuner.zacks.com/images/default_article_images/default97.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Earnings", "relevance_score": "0.999997"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.266143"}], "overall_sentiment_score": 0.155276, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "LLY", "relevance_score": "0.40348", "ticker_sentiment_score": "0.181105", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "PFE", "relevance_score": "0.140076", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}]}, {"title": "What's in the Cards for First Solar  ( FSLR )  in Q1 Earnings?", "url": "https://www.zacks.com/stock/news/2264764/whats-in-the-cards-for-first-solar-fslr-in-q1-earnings", "time_published": "20240430T115000", "authors": ["Zacks Equity Research"], "summary": "First Solar's (FSLR) Q1 results are likely to reflect the benefits of increased sales volume and average selling price per watt sold.", "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/6e/54381.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Earnings", "relevance_score": "0.999999"}, {"topic": "Life Sciences", "relevance_score": "0.5"}, {"topic": "Manufacturing", "relevance_score": "0.5"}], "overall_sentiment_score": 0.188767, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "FSLR", "relevance_score": "0.391486", "ticker_sentiment_score": "0.281344", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "RUN", "relevance_score": "0.116348", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "PFE", "relevance_score": "0.116348", "ticker_sentiment_score": "0.086248", "ticker_sentiment_label": "Neutral"}, {"ticker": "CSIQ", "relevance_score": "0.116348", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "NXT(EXP20091224)", "relevance_score": "0.05833", "ticker_sentiment_score": "0.067975", "ticker_sentiment_label": "Neutral"}, {"ticker": "CRYPTO:NXT", "relevance_score": "0.116348", "ticker_sentiment_score": "0.138853", "ticker_sentiment_label": "Neutral"}]}, {"title": "5 Top Stocks to Buy in May", "url": "https://www.fool.com/investing/2024/04/30/5-top-stocks-to-buy-in-may/", "time_published": "20240430T114500", "authors": ["and Neha Chamaria", "Keith Speights", "Demitri Kalogeropoulos", "Daniel Foelber", "Anders Bylund"], "summary": "Whether you're looking for a proven player, passive income, or a breakout growth story, there are plenty of stocks worth buying this spring.", "banner_image": "https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F774654%2Fgettyimages-1032524356-1201x691-f260cd6-1.jpg&op=resize&w=700", "source": "Motley Fool", "category_within_source": "n/a", "source_domain": "www.fool.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.25"}, {"topic": "Energy & Transportation", "relevance_score": "0.25"}, {"topic": "Technology", "relevance_score": "0.25"}, {"topic": "Economy - Monetary", "relevance_score": "0.310843"}, {"topic": "Retail & Wholesale", "relevance_score": "0.25"}, {"topic": "Financial Markets", "relevance_score": "0.999976"}, {"topic": "Earnings", "relevance_score": "1.0"}], "overall_sentiment_score": 0.236543, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "MSFT", "relevance_score": "0.225321", "ticker_sentiment_score": "0.213748", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "NFLX", "relevance_score": "0.022837", "ticker_sentiment_score": "0.079317", "ticker_sentiment_label": "Neutral"}, {"ticker": "FVRR", "relevance_score": "0.225321", "ticker_sentiment_score": "0.054189", "ticker_sentiment_label": "Neutral"}, {"ticker": "ZM", "relevance_score": "0.022837", "ticker_sentiment_score": "0.079317", "ticker_sentiment_label": "Neutral"}, {"ticker": "HD", "relevance_score": "0.158818", "ticker_sentiment_score": "0.08883", "ticker_sentiment_label": "Neutral"}, {"ticker": "PFE", "relevance_score": "0.20331", "ticker_sentiment_score": "0.13621", "ticker_sentiment_label": "Neutral"}, {"ticker": "NEE", "relevance_score": "0.181137", "ticker_sentiment_score": "0.188922", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "1 Magnificent Dividend Growth Stock That's Down 40% and Trading at a Once-in-a-Decade Valuation", "url": "https://www.fool.com/investing/2024/04/30/1-unstoppable-dividend-growth-stock-to-buy-right/", "time_published": "20240430T110000", "authors": ["Josh Kohn-Lindquist"], "summary": "The temporary problems facing Zoetis could create an incredible opportunity for investors thinking decades ahead.", "banner_image": "https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F773731%2Fgetty-happy-interested-cat-and-dog.jpg&op=resize&w=700", "source": "Motley Fool", "category_within_source": "n/a", "source_domain": "www.fool.com", "topics": [{"topic": "Earnings", "relevance_score": "0.961735"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.161647"}], "overall_sentiment_score": 0.146802, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "ZTS", "relevance_score": "0.871815", "ticker_sentiment_score": "0.241117", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "PFE", "relevance_score": "0.048523", "ticker_sentiment_score": "-0.007952", "ticker_sentiment_label": "Neutral"}]}, {"title": "Council Post: From Stigma To Support: Empowering Progress Despite Barriers In Breast Cancer", "url": "https://www.forbes.com/sites/forbesnonprofitcouncil/2024/04/30/from-stigma-to-support-empowering-progress-despite-barriers-in-breast-cancer/", "time_published": "20240430T110000", "authors": ["Paula Schneider"], "summary": "From Stigma To Support: Empowering Progress Despite Barriers In Breast Cancer Forbes ...", "banner_image": "https://blogs-images.forbes.com/assets/images/avatars/blog-4170_400_549922d942cda9fc4a4df59762a59086.jpg", "source": "Forbes", "category_within_source": "n/a", "source_domain": "www.forbes.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}], "overall_sentiment_score": 0.088926, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "PFE", "relevance_score": "0.035929", "ticker_sentiment_score": "0.107362", "ticker_sentiment_label": "Neutral"}]}, {"title": "Why I'm Buying This Beaten-Down, High-Yield Dividend Stock Hand Over Fist", "url": "https://www.fool.com/investing/2024/04/30/buying-beaten-down-high-yield-dividend-stock/", "time_published": "20240430T095000", "authors": ["Keith Speights"], "summary": "The sun could be peeking through the dark clouds for Pfizer.", "banner_image": "https://g.foolcdn.com/editorial/images/774882/scientists-looking-at-screen-with-icons.jpg", "source": "Motley Fool", "category_within_source": "n/a", "source_domain": "www.fool.com", "topics": [{"topic": "Earnings", "relevance_score": "0.995973"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.459462"}], "overall_sentiment_score": 0.072607, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "BHVN", "relevance_score": "0.063091", "ticker_sentiment_score": "0.042048", "ticker_sentiment_label": "Neutral"}, {"ticker": "PFE", "relevance_score": "0.616089", "ticker_sentiment_score": "0.121425", "ticker_sentiment_label": "Neutral"}]}, {"title": "Forget Nvidia: Prominent Billionaires Are Selling It and Buying These 2 Ultra-High-Yield Dividend Stocks Instead", "url": "https://www.fool.com/investing/2024/04/30/forget-nvidia-billionaires-sell-buy-dividend-stock/", "time_published": "20240430T090600", "authors": ["Sean Williams"], "summary": "Wall Street's brightest, most successful billionaire money managers are ditching Nvidia in favor of two time-tested income stocks with yields of 6.6%!", "banner_image": "https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F774824%2Fbuy-sell-stock-market-rolling-dice-getty.jpg&op=resize&w=700", "source": "Motley Fool", "category_within_source": "n/a", "source_domain": "www.fool.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.333333"}, {"topic": "Financial Markets", "relevance_score": "1.0"}, {"topic": "Manufacturing", "relevance_score": "0.333333"}, {"topic": "Earnings", "relevance_score": "0.992549"}, {"topic": "Technology", "relevance_score": "0.333333"}], "overall_sentiment_score": 0.228602, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "AMD", "relevance_score": "0.029043", "ticker_sentiment_score": "0.099927", "ticker_sentiment_label": "Neutral"}, {"ticker": "NVDA", "relevance_score": "0.337811", "ticker_sentiment_score": "0.257979", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "T", "relevance_score": "0.201164", "ticker_sentiment_score": "0.081382", "ticker_sentiment_label": "Neutral"}, {"ticker": "PFE", "relevance_score": "0.229149", "ticker_sentiment_score": "0.251834", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "MicroStrategy  ( MSTR )  Q1 2024 Earnings Call Transcript", "url": "https://www.fool.com/earnings/call-transcripts/2024/04/29/microstrategy-mstr-q1-2024-earnings-call-transcrip/", "time_published": "20240430T013016", "authors": ["Motley Fool Transcribing"], "summary": "MSTR earnings call for the period ending March 31, 2024.", "banner_image": "https://g.foolcdn.com/misc-assets/fool-transcripts-logo.png", "source": "Motley Fool", "category_within_source": "n/a", "source_domain": "www.fool.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.333333"}, {"topic": "Technology", "relevance_score": "0.333333"}, {"topic": "Blockchain", "relevance_score": "0.838487"}, {"topic": "Economy - Monetary", "relevance_score": "0.769861"}, {"topic": "Retail & Wholesale", "relevance_score": "0.333333"}, {"topic": "Financial Markets", "relevance_score": "1.0"}, {"topic": "Earnings", "relevance_score": "1.0"}, {"topic": "Mergers & Acquisitions", "relevance_score": "0.316726"}], "overall_sentiment_score": 0.250011, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "MSFT", "relevance_score": "0.010784", "ticker_sentiment_score": "0.142069", "ticker_sentiment_label": "Neutral"}, {"ticker": "MSTR", "relevance_score": "0.150089", "ticker_sentiment_score": "0.160685", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "GOOG", "relevance_score": "0.016176", "ticker_sentiment_score": "0.108467", "ticker_sentiment_label": "Neutral"}, {"ticker": "VSCO", "relevance_score": "0.005392", "ticker_sentiment_score": "0.09122", "ticker_sentiment_label": "Neutral"}, {"ticker": "AWON", "relevance_score": "0.005392", "ticker_sentiment_score": "0.03595", "ticker_sentiment_label": "Neutral"}, {"ticker": "PFE", "relevance_score": "0.005392", "ticker_sentiment_score": "0.09122", "ticker_sentiment_label": "Neutral"}, {"ticker": "BNXYF", "relevance_score": "0.005392", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "CRYPTO:BTC", "relevance_score": "0.692509", "ticker_sentiment_score": "0.435991", "ticker_sentiment_label": "Bullish"}, {"ticker": "CRYPTO:BTG", "relevance_score": "0.005392", "ticker_sentiment_score": "0.024172", "ticker_sentiment_label": "Neutral"}]}, {"title": "TIVDAK\u00ae  ( tisotumab vedotin-tftv )  Receives U.S. FDA Approval to Treat Recurrent or Metastatic Cervical Cancer", "url": "https://www.globenewswire.com/news-release/2024/04/29/2871730/0/en/TIVDAK-tisotumab-vedotin-tftv-Receives-U-S-FDA-Approval-to-Treat-Recurrent-or-Metastatic-Cervical-Cancer.html", "time_published": "20240429T224000", "authors": ["Genmab A/S"], "summary": "Company Announcement ...", "banner_image": "https://ml-eu.globenewswire.com/Resource/Download/368a5dab-dfc5-4e1d-bfa6-2af5e5216fce", "source": "GlobeNewswire", "category_within_source": "n/a", "source_domain": "www.globenewswire.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.310843"}], "overall_sentiment_score": 0.024509, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "GMAB", "relevance_score": "0.252114", "ticker_sentiment_score": "0.145453", "ticker_sentiment_label": "Neutral"}, {"ticker": "PFE", "relevance_score": "0.186346", "ticker_sentiment_score": "0.079283", "ticker_sentiment_label": "Neutral"}]}, {"title": "GNC is struggling. It hopes Ozempic can give it a boost | Business", "url": "https://www.cnn.com/2024/04/29/business/gnc-ozempic-wegovy-novo-nordisk-strategy/index.html", "time_published": "20240429T195730", "authors": ["Nathaniel Meyersohn"], "summary": "GNC is struggling. It hopes Ozempic can give it a boost ...", "banner_image": "https://media.cnn.com/api/v1/images/stellar/prod/02-20240429174742656.jpg?q=w_1110,c_fill", "source": "CNN", "category_within_source": "Markets", "source_domain": "www.cnn.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.5"}, {"topic": "Technology", "relevance_score": "0.5"}], "overall_sentiment_score": 0.059918, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "LTH", "relevance_score": "0.07913", "ticker_sentiment_score": "-0.032882", "ticker_sentiment_label": "Neutral"}, {"ticker": "NSRGF", "relevance_score": "0.07913", "ticker_sentiment_score": "0.067964", "ticker_sentiment_label": "Neutral"}, {"ticker": "NVO", "relevance_score": "0.07913", "ticker_sentiment_score": "0.141066", "ticker_sentiment_label": "Neutral"}, {"ticker": "PFE", "relevance_score": "0.07913", "ticker_sentiment_score": "0.141066", "ticker_sentiment_label": "Neutral"}]}, {"title": "Here's How to Play Pfizer  ( PFE )  Stock Ahead of Q1 Earnings", "url": "https://www.zacks.com/stock/news/2264363/heres-how-to-play-pfizer-pfe-stock-ahead-of-q1-earnings", "time_published": "20240429T161200", "authors": ["Kinjel Shah"], "summary": "Pfizer (PFE) expects its operational revenues to improve, driven by its in-line products like Vyndaqel, new launches like Abrysvo and newly acquired products, including those acquired from Seagen.", "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/89/447.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.998356"}, {"topic": "Earnings", "relevance_score": "0.614606"}, {"topic": "Mergers & Acquisitions", "relevance_score": "0.316726"}], "overall_sentiment_score": 0.105696, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "BHVN", "relevance_score": "0.044222", "ticker_sentiment_score": "0.156404", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "PFE", "relevance_score": "0.625053", "ticker_sentiment_score": "0.23877", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "BNTX", "relevance_score": "0.132125", "ticker_sentiment_score": "0.154238", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "What Makes Amazon Attractive Ahead of Q1 Earnings? - Amazon.com  ( NASDAQ:AMZN ) , Delta Air Lines  ( NYSE:DAL ) ", "url": "https://www.benzinga.com/news/earnings/24/04/38490827/what-makes-amazon-attractive-ahead-of-q1-earnings", "time_published": "20240429T161121", "authors": ["Zacks"], "summary": "Seattle-based Amazon.com, Inc. AMZN, with a market capitalization of more than $1.8 trillion, is one of the most valuable companies worldwide. Amazon is the frontrunner in the e-commerce and cloud computing space. Jeff Bezos' company has also ventured into AI to propel its growth and boasts a ...", "banner_image": "https://cdn.benzinga.com/files/images/story/2024/04/29/sunrise-king-hictpu2pa8e-unsplash.jpg?width=1200&height=800&fit=crop", "source": "Benzinga", "category_within_source": "Trading", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.25"}, {"topic": "Retail & Wholesale", "relevance_score": "0.25"}, {"topic": "Financial Markets", "relevance_score": "0.962106"}, {"topic": "Earnings", "relevance_score": "0.999858"}, {"topic": "Energy & Transportation", "relevance_score": "0.25"}, {"topic": "Technology", "relevance_score": "0.25"}], "overall_sentiment_score": 0.29403, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "MSFT", "relevance_score": "0.09989", "ticker_sentiment_score": "0.06596", "ticker_sentiment_label": "Neutral"}, {"ticker": "GOOG", "relevance_score": "0.050044", "ticker_sentiment_score": "0.0609", "ticker_sentiment_label": "Neutral"}, {"ticker": "INTU", "relevance_score": "0.09989", "ticker_sentiment_score": "0.144808", "ticker_sentiment_label": "Neutral"}, {"ticker": "AMZN", "relevance_score": "0.766922", "ticker_sentiment_score": "0.458846", "ticker_sentiment_label": "Bullish"}, {"ticker": "DAL", "relevance_score": "0.09989", "ticker_sentiment_score": "0.144808", "ticker_sentiment_label": "Neutral"}, {"ticker": "PFE", "relevance_score": "0.09989", "ticker_sentiment_score": "0.144808", "ticker_sentiment_label": "Neutral"}]}, {"title": "mRNA Is Promising A Breakthrough In Fighting Cancer - Pfizer  ( NYSE:PFE ) ", "url": "https://www.benzinga.com/markets/penny-stocks/24/04/38491524/mrna-is-promising-a-breakthrough-in-fighting-cancer", "time_published": "20240429T140243", "authors": ["Upwallstreet"], "summary": "When it comes to cancer, there's innovation both on the diagnostics and the treatment front thanks to messenger RNA, or mRNA, a genetic material we all got acquainted with during the COVID-19 era as it allowed pharmaceutical companies like Pfizer Inc PFE and Moderna Inc MRNA to develop their ...", "banner_image": "https://cdn.benzinga.com/files/3d-render-medical-background-with-microscopic-view-abstract-virus-cell_1048-13421.jpg?width=1200&height=800&fit=crop", "source": "Benzinga", "category_within_source": "General", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.360215"}], "overall_sentiment_score": 0.09687, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "MRNA", "relevance_score": "0.371523", "ticker_sentiment_score": "-0.06442", "ticker_sentiment_label": "Neutral"}, {"ticker": "PFE", "relevance_score": "0.128135", "ticker_sentiment_score": "0.076952", "ticker_sentiment_label": "Neutral"}]}, {"title": "Why Pfizer  ( PFE )  is a Top Value Stock for the Long-Term", "url": "https://www.zacks.com/stock/news/2264092/why-pfizer-pfe-is-a-top-value-stock-for-the-long-term", "time_published": "20240429T134011", "authors": ["Zacks Equity Research"], "summary": "Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.", "banner_image": "https://staticx-tuner.zacks.com/images/default_article_images/default182.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Earnings", "relevance_score": "0.682689"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.538269"}], "overall_sentiment_score": 0.399512, "overall_sentiment_label": "Bullish", "ticker_sentiment": [{"ticker": "PFE", "relevance_score": "0.465901", "ticker_sentiment_score": "0.250646", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "What Makes Amazon  ( AMZN )  Attractive Ahead of Q1 Earnings?", "url": "https://www.zacks.com/stock/news/2263925/what-makes-amazon-amzn-attractive-ahead-of-q1-earnings", "time_published": "20240429T121500", "authors": ["Tirthankar Chakraborty"], "summary": "Sustained growth in advertising business and acceleration in AWS make Amazon (AMZN) an enticing buy heading into its first-quarter earnings release.", "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/92/486.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.25"}, {"topic": "Retail & Wholesale", "relevance_score": "0.25"}, {"topic": "Financial Markets", "relevance_score": "0.929393"}, {"topic": "Earnings", "relevance_score": "0.999858"}, {"topic": "Energy & Transportation", "relevance_score": "0.25"}, {"topic": "Technology", "relevance_score": "0.25"}], "overall_sentiment_score": 0.278129, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "MSFT", "relevance_score": "0.09989", "ticker_sentiment_score": "0.053835", "ticker_sentiment_label": "Neutral"}, {"ticker": "GOOG", "relevance_score": "0.050044", "ticker_sentiment_score": "0.049861", "ticker_sentiment_label": "Neutral"}, {"ticker": "INTU", "relevance_score": "0.09989", "ticker_sentiment_score": "0.125242", "ticker_sentiment_label": "Neutral"}, {"ticker": "AMZN", "relevance_score": "0.766922", "ticker_sentiment_score": "0.449036", "ticker_sentiment_label": "Bullish"}, {"ticker": "DAL", "relevance_score": "0.09989", "ticker_sentiment_score": "0.125242", "ticker_sentiment_label": "Neutral"}, {"ticker": "PFE", "relevance_score": "0.09989", "ticker_sentiment_score": "0.125242", "ticker_sentiment_label": "Neutral"}]}, {"title": "3 Beaten-Down Stocks I Wouldn't Touch With a 10-Foot Pole", "url": "https://www.fool.com/investing/2024/04/29/3-beaten-down-stocks-i-wouldnt-touch-with-a-10-foo/", "time_published": "20240429T121000", "authors": ["Prosper Junior Bakiny"], "summary": "These stocks aren't bargains.", "banner_image": "https://media.ycharts.com/charts/70b912a671d9768c34fb453f70ed3f24.png", "source": "Motley Fool", "category_within_source": "n/a", "source_domain": "www.fool.com", "topics": [{"topic": "Earnings", "relevance_score": "0.495866"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.161647"}], "overall_sentiment_score": 0.063412, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "ACB", "relevance_score": "0.344302", "ticker_sentiment_score": "0.10151", "ticker_sentiment_label": "Neutral"}, {"ticker": "CHGG", "relevance_score": "0.201105", "ticker_sentiment_score": "0.125081", "ticker_sentiment_label": "Neutral"}, {"ticker": "NVAX", "relevance_score": "0.344302", "ticker_sentiment_score": "0.128908", "ticker_sentiment_label": "Neutral"}, {"ticker": "MRNA", "relevance_score": "0.101367", "ticker_sentiment_score": "0.023886", "ticker_sentiment_label": "Neutral"}, {"ticker": "PFE", "relevance_score": "0.101367", "ticker_sentiment_score": "0.023886", "ticker_sentiment_label": "Neutral"}]}, {"title": "Petauri\u2122 Announces 2 Key Hires at Petauri Advisors", "url": "https://www.prnewswire.com/news-releases/petauri-announces-2-key-hires-at-petauri-advisors-302129767.html", "time_published": "20240429T120000", "authors": ["Petauri"], "summary": "NASHVILLE, Tenn., April 29, 2024 /PRNewswire/ -- Petauri Advisors, a strategic life sciences consulting business unit of Petauri, a leading purpose-built pharmaceutical services platform, announced today that it has added to its executive ranks 2 experienced leaders who bring extensive market ...", "banner_image": "https://mma.prnewswire.com/media/2321364/Petauri_Color_Tag_Logo.jpg?p=facebook", "source": "PR Newswire", "category_within_source": "n/a", "source_domain": "www.prnewswire.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.5"}, {"topic": "Retail & Wholesale", "relevance_score": "0.5"}], "overall_sentiment_score": 0.36481, "overall_sentiment_label": "Bullish", "ticker_sentiment": [{"ticker": "CVS", "relevance_score": "0.050148", "ticker_sentiment_score": "0.105793", "ticker_sentiment_label": "Neutral"}, {"ticker": "PFE", "relevance_score": "0.050148", "ticker_sentiment_score": "0.105793", "ticker_sentiment_label": "Neutral"}]}, {"title": "Tesla, Alphabet, SoFi, Paramount, Apple, Domino's, and More Stock Market Movers", "url": "https://www.barrons.com/amp/articles/stock-market-movers-4c54f840", "time_published": "20240429T082800", "authors": ["Joe Woelfel"], "summary": "Tesla, Alphabet, Fulton Financial, SoFi, Apple, Amazon, and More Stock Market Movers ...", "banner_image": "https://images.barrons.com/im-568061/social", "source": "Barrons", "category_within_source": "n/a", "source_domain": "www.barrons.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.142857"}, {"topic": "Energy & Transportation", "relevance_score": "0.142857"}, {"topic": "Technology", "relevance_score": "0.142857"}, {"topic": "Finance", "relevance_score": "0.142857"}, {"topic": "Retail & Wholesale", "relevance_score": "0.142857"}, {"topic": "Financial Markets", "relevance_score": "0.161647"}, {"topic": "Manufacturing", "relevance_score": "0.142857"}, {"topic": "Earnings", "relevance_score": "0.917436"}, {"topic": "Real Estate & Construction", "relevance_score": "0.142857"}], "overall_sentiment_score": 0.083564, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "MSTR", "relevance_score": "0.06515", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "CVS", "relevance_score": "0.06515", "ticker_sentiment_score": "-0.057048", "ticker_sentiment_label": "Neutral"}, {"ticker": "PARA", "relevance_score": "0.06515", "ticker_sentiment_score": "0.011101", "ticker_sentiment_label": "Neutral"}, {"ticker": "LOGI", "relevance_score": "0.06515", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "NVO", "relevance_score": "0.06515", "ticker_sentiment_score": "-0.057048", "ticker_sentiment_label": "Neutral"}, {"ticker": "BIDU", "relevance_score": "0.129866", "ticker_sentiment_score": "0.077058", "ticker_sentiment_label": "Neutral"}, {"ticker": "KHC", "relevance_score": "0.06515", "ticker_sentiment_score": "-0.057048", "ticker_sentiment_label": "Neutral"}, {"ticker": "DASH", "relevance_score": "0.06515", "ticker_sentiment_score": "-0.057048", "ticker_sentiment_label": "Neutral"}, {"ticker": "COIN", "relevance_score": "0.06515", "ticker_sentiment_score": "-0.057048", "ticker_sentiment_label": "Neutral"}, {"ticker": "PFE", "relevance_score": "0.06515", "ticker_sentiment_score": "-0.057048", "ticker_sentiment_label": "Neutral"}, {"ticker": "DPZ", "relevance_score": "0.06515", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "TSLA", "relevance_score": "0.256314", "ticker_sentiment_score": "0.124014", "ticker_sentiment_label": "Neutral"}, {"ticker": "MA", "relevance_score": "0.06515", "ticker_sentiment_score": "-0.057048", "ticker_sentiment_label": "Neutral"}, {"ticker": "SBUX", "relevance_score": "0.06515", "ticker_sentiment_score": "-0.057048", "ticker_sentiment_label": "Neutral"}, {"ticker": "QCOM", "relevance_score": "0.06515", "ticker_sentiment_score": "-0.057048", "ticker_sentiment_label": "Neutral"}, {"ticker": "AMD", "relevance_score": "0.06515", "ticker_sentiment_score": "-0.057048", "ticker_sentiment_label": "Neutral"}, {"ticker": "CHGG", "relevance_score": "0.06515", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "Z", "relevance_score": "0.06515", "ticker_sentiment_score": "-0.057048", "ticker_sentiment_label": "Neutral"}, {"ticker": "PINS", "relevance_score": "0.06515", "ticker_sentiment_score": "-0.057048", "ticker_sentiment_label": "Neutral"}, {"ticker": "FNLC", "relevance_score": "0.193723", "ticker_sentiment_score": "-0.182549", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "ON", "relevance_score": "0.06515", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "PYPL", "relevance_score": "0.06515", "ticker_sentiment_score": "-0.057048", "ticker_sentiment_label": "Neutral"}, {"ticker": "GOOG", "relevance_score": "0.06515", "ticker_sentiment_score": "0.113154", "ticker_sentiment_label": "Neutral"}, {"ticker": "KO", "relevance_score": "0.06515", "ticker_sentiment_score": "-0.057048", "ticker_sentiment_label": "Neutral"}, {"ticker": "COP", "relevance_score": "0.06515", "ticker_sentiment_score": "-0.057048", "ticker_sentiment_label": "Neutral"}, {"ticker": "SMCI", "relevance_score": "0.06515", "ticker_sentiment_score": "-0.057048", "ticker_sentiment_label": "Neutral"}, {"ticker": "NXPI", "relevance_score": "0.06515", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "DMPZF", "relevance_score": "0.06515", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "FSLR", "relevance_score": "0.06515", "ticker_sentiment_score": "-0.057048", "ticker_sentiment_label": "Neutral"}, {"ticker": "FRBK", "relevance_score": "0.193723", "ticker_sentiment_score": "-0.182549", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "EBAY", "relevance_score": "0.06515", "ticker_sentiment_score": "-0.057048", "ticker_sentiment_label": "Neutral"}, {"ticker": "FULT", "relevance_score": "0.06515", "ticker_sentiment_score": "-0.121175", "ticker_sentiment_label": "Neutral"}, {"ticker": "GEHC", "relevance_score": "0.06515", "ticker_sentiment_score": "-0.057048", "ticker_sentiment_label": "Neutral"}, {"ticker": "SOFI", "relevance_score": "0.06515", "ticker_sentiment_score": "0.36166", "ticker_sentiment_label": "Bullish"}, {"ticker": "MRNA", "relevance_score": "0.06515", "ticker_sentiment_score": "-0.057048", "ticker_sentiment_label": "Neutral"}]}, {"title": "Pieris Pharmaceuticals  ( NASDAQ:PIRS )  Coverage Initiated at StockNews.com", "url": "https://www.defenseworld.net/2024/04/29/pieris-pharmaceuticals-nasdaqpirs-coverage-initiated-at-stocknews-com.html", "time_published": "20240429T075626", "authors": ["Defense World Staff"], "summary": "Analysts at StockNews.com assumed coverage on shares of Pieris Pharmaceuticals ( NASDAQ:PIRS - Get Free Report ) in a research note issued on Monday. The brokerage set a \"hold\" rating on the biotechnology company's stock. Shares of Pieris Pharmaceuticals stock opened at $11.72 on Monday.", "banner_image": "https://www.marketbeat.com/logos/pieris-pharmaceuticals-inc-logo-1200x675.jpg", "source": "Stocknews.com", "category_within_source": "n/a", "source_domain": "www.defenseworld.net", "topics": [{"topic": "Earnings", "relevance_score": "0.818451"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.87644"}], "overall_sentiment_score": 0.131681, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "PFE", "relevance_score": "0.118647", "ticker_sentiment_score": "0.077367", "ticker_sentiment_label": "Neutral"}, {"ticker": "AWON", "relevance_score": "0.118647", "ticker_sentiment_score": "0.001138", "ticker_sentiment_label": "Neutral"}, {"ticker": "PIRS", "relevance_score": "0.82082", "ticker_sentiment_score": "0.223162", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "Will Earnings Cheer Continue To Buoy Markets? Apple, Amazon, Pfizer, Coinbase Lead Flurry Of Q1 Reports This Week - Invesco QQQ Trust, Series 1  ( NASDAQ:QQQ ) , SPDR S&P 500  ( ARCA:SPY ) ", "url": "https://www.benzinga.com/news/earnings/24/04/38481553/will-earnings-cheer-continue-to-buoy-markets-apple-amazon-pfizer-coinbase-lead-flurry-of-q1-reports", "time_published": "20240429T055121", "authors": ["Shanthi Rexaline"], "summary": "Corporate earnings came to the market's rescue in the past week, helping to overcome rate fears. As we look ahead to the unfolding week, it remains to be seen whether the tech earnings deluge can keep the rally's momentum going.", "banner_image": "https://cdn.benzinga.com/files/images/story/2024/04/29/Market.png?width=1200&height=800&fit=crop", "source": "Benzinga", "category_within_source": "News", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.142857"}, {"topic": "Energy & Transportation", "relevance_score": "0.142857"}, {"topic": "Technology", "relevance_score": "0.142857"}, {"topic": "Finance", "relevance_score": "0.142857"}, {"topic": "Retail & Wholesale", "relevance_score": "0.142857"}, {"topic": "Financial Markets", "relevance_score": "0.961735"}, {"topic": "Manufacturing", "relevance_score": "0.142857"}, {"topic": "Earnings", "relevance_score": "0.999917"}, {"topic": "Real Estate & Construction", "relevance_score": "0.142857"}], "overall_sentiment_score": 0.260382, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "DD", "relevance_score": "0.069294", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "MSTR", "relevance_score": "0.069294", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "ALL", "relevance_score": "0.03468", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "AAPL", "relevance_score": "0.239137", "ticker_sentiment_score": "0.076466", "ticker_sentiment_label": "Neutral"}, {"ticker": "LSCC", "relevance_score": "0.069294", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "LOGI", "relevance_score": "0.069294", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "KHC", "relevance_score": "0.069294", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "NOVA", "relevance_score": "0.069294", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "UPWK", "relevance_score": "0.069294", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "AMGN", "relevance_score": "0.069294", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "COIN", "relevance_score": "0.069294", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "PFE", "relevance_score": "0.069294", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "TSLA", "relevance_score": "0.069294", "ticker_sentiment_score": "0.271882", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "MA", "relevance_score": "0.03468", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "NTGR", "relevance_score": "0.069294", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "KLIC", "relevance_score": "0.069294", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "QGEN", "relevance_score": "0.069294", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "FIVN", "relevance_score": "0.069294", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "YUMC", "relevance_score": "0.069294", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "ED", "relevance_score": "0.069294", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "DKNG", "relevance_score": "0.069294", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "META", "relevance_score": "0.069294", "ticker_sentiment_score": "0.120474", "ticker_sentiment_label": "Neutral"}, {"ticker": "EG", "relevance_score": "0.069294", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "WING", "relevance_score": "0.069294", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "ILMN", "relevance_score": "0.069294", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "MT", "relevance_score": "0.069294", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "BLCO", "relevance_score": "0.069294", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "OMI", "relevance_score": "0.069294", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "SANM", "relevance_score": "0.069294", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "RGA", "relevance_score": "0.069294", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "KIM", "relevance_score": "0.069294", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "HSY", "relevance_score": "0.069294", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "YUM", "relevance_score": "0.069294", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "FSLR", "relevance_score": "0.069294", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "EBAY", "relevance_score": "0.069294", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "SOFI", "relevance_score": "0.069294", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "MRNA", "relevance_score": "0.069294", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "QRVO", "relevance_score": "0.069294", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "MET", "relevance_score": "0.069294", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "PXD", "relevance_score": "0.069294", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "CVS", "relevance_score": "0.069294", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "PARA", "relevance_score": "0.069294", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "EXPE", "relevance_score": "0.069294", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "MRO", "relevance_score": "0.069294", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "IVZ", "relevance_score": "0.03468", "ticker_sentiment_score": "0.111638", "ticker_sentiment_label": "Neutral"}, {"ticker": "FFIV", "relevance_score": "0.069294", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "FLR", "relevance_score": "0.069294", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "PENN", "relevance_score": "0.069294", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "NCLH", "relevance_score": "0.069294", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "XPO", "relevance_score": "0.069294", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "W", "relevance_score": "0.069294", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "X", "relevance_score": "0.069294", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "ZTS", "relevance_score": "0.069294", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "CYBR", "relevance_score": "0.069294", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "Z", "relevance_score": "0.03468", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "BKNG", "relevance_score": "0.069294", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "GSK", "relevance_score": "0.069294", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "ON", "relevance_score": "0.03468", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "COP", "relevance_score": "0.069294", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "MNST", "relevance_score": "0.069294", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "NXPI", "relevance_score": "0.069294", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "LYV", "relevance_score": "0.069294", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "CBOE", "relevance_score": "0.069294", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "ICE", "relevance_score": "0.069294", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "RMBS", "relevance_score": "0.069294", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "GRMN", "relevance_score": "0.069294", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "OPEN", "relevance_score": "0.069294", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "BZH", "relevance_score": "0.069294", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "MGM", "relevance_score": "0.069294", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "AXL", "relevance_score": "0.069294", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "ETSY", "relevance_score": "0.069294", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "REG", "relevance_score": "0.069294", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "ALB", "relevance_score": "0.069294", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "WOLF", "relevance_score": "0.069294", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "NET", "relevance_score": "0.069294", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "DVN", "relevance_score": "0.069294", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "AMZN", "relevance_score": "0.138066", "ticker_sentiment_score": "0.214972", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "Lyme disease bites as ticks gain ground in US", "url": "https://www.ft.com/content/482e3eb0-cc26-4ef7-a53f-828a86303a34", "time_published": "20240429T033012", "authors": ["Andrew Jack"], "summary": "Changing climate and human population shifts have spread and strengthened foothold ...", "banner_image": "https://www.ft.com/__origami/service/image/v2/images/raw/https%3A%2F%2Fpublic.flourish.studio%2Fvisualisation%2F17628402%2Fthumbnail?source=next-article&fit=scale-down&quality=highest&width=1020&dpr=1", "source": "Financial Times", "category_within_source": "Companies", "source_domain": "www.ft.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.5"}, {"topic": "Technology", "relevance_score": "0.5"}], "overall_sentiment_score": -0.074383, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "VALN", "relevance_score": "0.044469", "ticker_sentiment_score": "0.05282", "ticker_sentiment_label": "Neutral"}, {"ticker": "PFE", "relevance_score": "0.044469", "ticker_sentiment_score": "0.05282", "ticker_sentiment_label": "Neutral"}]}, {"title": "Apple and Amazon Earnings, the Fed, Jobs Data, and More to Watch", "url": "https://www.barrons.com/amp/articles/apple-amd-amazon-earnings-fed-rate-decision-jobs-data-ac49c8d4", "time_published": "20240428T200000", "authors": ["Nicholas Jasinski"], "summary": "Apple and Amazon Earnings, Fed Rate Decision, Jobs Data, and More to Watch This Week ...", "banner_image": "https://images.barrons.com/im-822056/social", "source": "Barrons", "category_within_source": "n/a", "source_domain": "www.barrons.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.142857"}, {"topic": "Energy & Transportation", "relevance_score": "0.142857"}, {"topic": "Technology", "relevance_score": "0.142857"}, {"topic": "Finance", "relevance_score": "0.142857"}, {"topic": "Economy - Monetary", "relevance_score": "0.890401"}, {"topic": "Economy - Fiscal", "relevance_score": "0.158519"}, {"topic": "Retail & Wholesale", "relevance_score": "0.142857"}, {"topic": "Manufacturing", "relevance_score": "0.142857"}, {"topic": "Earnings", "relevance_score": "0.158519"}, {"topic": "Real Estate & Construction", "relevance_score": "0.142857"}], "overall_sentiment_score": -0.007118, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "DD", "relevance_score": "0.071784", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "CVS", "relevance_score": "0.142989", "ticker_sentiment_score": "0.026999", "ticker_sentiment_label": "Neutral"}, {"ticker": "CTVA", "relevance_score": "0.071784", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "PARA", "relevance_score": "0.142989", "ticker_sentiment_score": "0.041772", "ticker_sentiment_label": "Neutral"}, {"ticker": "AFL", "relevance_score": "0.071784", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "KHC", "relevance_score": "0.071784", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "MRO", "relevance_score": "0.071784", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "PFE", "relevance_score": "0.142989", "ticker_sentiment_score": "0.026999", "ticker_sentiment_label": "Neutral"}, {"ticker": "DPZ", "relevance_score": "0.142989", "ticker_sentiment_score": "0.041772", "ticker_sentiment_label": "Neutral"}, {"ticker": "MA", "relevance_score": "0.142989", "ticker_sentiment_score": "0.026999", "ticker_sentiment_label": "Neutral"}, {"ticker": "NCLH", "relevance_score": "0.071784", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "QCOM", "relevance_score": "0.142989", "ticker_sentiment_score": "0.026999", "ticker_sentiment_label": "Neutral"}, {"ticker": "VTR", "relevance_score": "0.071784", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "SBAC", "relevance_score": "0.071784", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "AMD", "relevance_score": "0.071784", "ticker_sentiment_score": "0.045222", "ticker_sentiment_label": "Neutral"}, {"ticker": "BKNG", "relevance_score": "0.071784", "ticker_sentiment_score": "0.045222", "ticker_sentiment_label": "Neutral"}, {"ticker": "AIG", "relevance_score": "0.071784", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "ON", "relevance_score": "0.071784", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "COP", "relevance_score": "0.071784", "ticker_sentiment_score": "0.045222", "ticker_sentiment_label": "Neutral"}, {"ticker": "MNST", "relevance_score": "0.071784", "ticker_sentiment_score": "0.045222", "ticker_sentiment_label": "Neutral"}, {"ticker": "SMCI", "relevance_score": "0.071784", "ticker_sentiment_score": "0.045222", "ticker_sentiment_label": "Neutral"}, {"ticker": "WELL", "relevance_score": "0.071784", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "BEN", "relevance_score": "0.071784", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "RVTY", "relevance_score": "0.071784", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "YUM", "relevance_score": "0.071784", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "DMPZF", "relevance_score": "0.142989", "ticker_sentiment_score": "0.041772", "ticker_sentiment_label": "Neutral"}, {"ticker": "VICI", "relevance_score": "0.071784", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "FSLR", "relevance_score": "0.071784", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "MGM", "relevance_score": "0.071784", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "ETSY", "relevance_score": "0.142989", "ticker_sentiment_score": "0.026999", "ticker_sentiment_label": "Neutral"}, {"ticker": "ALB", "relevance_score": "0.071784", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "GNRC", "relevance_score": "0.071784", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "MRNA", "relevance_score": "0.071784", "ticker_sentiment_score": "0.045222", "ticker_sentiment_label": "Neutral"}, {"ticker": "QRVO", "relevance_score": "0.071784", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "DVN", "relevance_score": "0.071784", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "MET", "relevance_score": "0.071784", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "MAR", "relevance_score": "0.071784", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}]}, {"title": "Is Viking Therapeutics Incredibly Undervalued?", "url": "https://www.fool.com/investing/2024/04/28/is-viking-therapeutics-incredibly-undervalued/", "time_published": "20240428T143000", "authors": ["George Budwell"], "summary": "The biotech's weight loss drug candidate could fuel a premium-laden buyout, but risks abound.", "banner_image": "https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F774718%2Fvalue-stock.jpg&op=resize&w=700", "source": "Motley Fool", "category_within_source": "n/a", "source_domain": "www.fool.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.5"}, {"topic": "Finance", "relevance_score": "0.5"}, {"topic": "Financial Markets", "relevance_score": "0.108179"}], "overall_sentiment_score": 0.144914, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "LLY", "relevance_score": "0.257668", "ticker_sentiment_score": "0.051931", "ticker_sentiment_label": "Neutral"}, {"ticker": "VKTX", "relevance_score": "0.257668", "ticker_sentiment_score": "0.122681", "ticker_sentiment_label": "Neutral"}, {"ticker": "GS", "relevance_score": "0.065506", "ticker_sentiment_score": "-0.038132", "ticker_sentiment_label": "Neutral"}, {"ticker": "NVO", "relevance_score": "0.257668", "ticker_sentiment_score": "0.051931", "ticker_sentiment_label": "Neutral"}, {"ticker": "PFE", "relevance_score": "0.065506", "ticker_sentiment_score": "0.211582", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "What is divestment? And does it work? | Business", "url": "https://edition.cnn.com/2024/04/28/investing/stocks-lookahead-divestment-college-protests/index.html", "time_published": "20240428T113000", "authors": ["Nicole Goodkind"], "summary": "What is divestment? And does it work? CNN International ...", "banner_image": "https://media.cnn.com/api/v1/images/stellar/prod/240425130717-11-university-campus-protests-unf.jpg?c=16x9&q=w_800,c_fill", "source": "CNN", "category_within_source": "Markets", "source_domain": "edition.cnn.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.166667"}, {"topic": "Energy & Transportation", "relevance_score": "0.166667"}, {"topic": "Technology", "relevance_score": "0.166667"}, {"topic": "Economy - Monetary", "relevance_score": "0.990678"}, {"topic": "Economy - Fiscal", "relevance_score": "0.158519"}, {"topic": "Retail & Wholesale", "relevance_score": "0.166667"}, {"topic": "Financial Markets", "relevance_score": "0.929393"}, {"topic": "Manufacturing", "relevance_score": "0.166667"}, {"topic": "Earnings", "relevance_score": "0.682689"}, {"topic": "Real Estate & Construction", "relevance_score": "0.166667"}], "overall_sentiment_score": -0.038818, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "DKNG", "relevance_score": "0.032078", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "PYPL", "relevance_score": "0.032078", "ticker_sentiment_score": "0.124953", "ticker_sentiment_label": "Neutral"}, {"ticker": "MDLZ", "relevance_score": "0.032078", "ticker_sentiment_score": "0.124953", "ticker_sentiment_label": "Neutral"}, {"ticker": "KO", "relevance_score": "0.032078", "ticker_sentiment_score": "0.124953", "ticker_sentiment_label": "Neutral"}, {"ticker": "MDNDF", "relevance_score": "0.032078", "ticker_sentiment_score": "0.124953", "ticker_sentiment_label": "Neutral"}, {"ticker": "COP", "relevance_score": "0.032078", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "NVO", "relevance_score": "0.032078", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "DASH", "relevance_score": "0.032078", "ticker_sentiment_score": "0.102753", "ticker_sentiment_label": "Neutral"}, {"ticker": "PFE", "relevance_score": "0.032078", "ticker_sentiment_score": "0.102753", "ticker_sentiment_label": "Neutral"}, {"ticker": "DPZ", "relevance_score": "0.032078", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "SSNLF", "relevance_score": "0.032078", "ticker_sentiment_score": "0.124953", "ticker_sentiment_label": "Neutral"}, {"ticker": "DMPZF", "relevance_score": "0.032078", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "QSR", "relevance_score": "0.032078", "ticker_sentiment_score": "0.124953", "ticker_sentiment_label": "Neutral"}, {"ticker": "FANG", "relevance_score": "0.032078", "ticker_sentiment_score": "0.124953", "ticker_sentiment_label": "Neutral"}, {"ticker": "MA", "relevance_score": "0.032078", "ticker_sentiment_score": "0.102753", "ticker_sentiment_label": "Neutral"}, {"ticker": "SBUX", "relevance_score": "0.032078", "ticker_sentiment_score": "0.124953", "ticker_sentiment_label": "Neutral"}, {"ticker": "EBAY", "relevance_score": "0.032078", "ticker_sentiment_score": "0.102753", "ticker_sentiment_label": "Neutral"}, {"ticker": "ETSY", "relevance_score": "0.032078", "ticker_sentiment_score": "0.102753", "ticker_sentiment_label": "Neutral"}, {"ticker": "QCOM", "relevance_score": "0.032078", "ticker_sentiment_score": "0.102753", "ticker_sentiment_label": "Neutral"}, {"ticker": "WBD", "relevance_score": "0.032078", "ticker_sentiment_score": "0.02687", "ticker_sentiment_label": "Neutral"}, {"ticker": "CZR", "relevance_score": "0.032078", "ticker_sentiment_score": "0.124953", "ticker_sentiment_label": "Neutral"}, {"ticker": "PINS", "relevance_score": "0.032078", "ticker_sentiment_score": "0.124953", "ticker_sentiment_label": "Neutral"}, {"ticker": "FOREX:EUR", "relevance_score": "0.032078", "ticker_sentiment_score": "-0.153159", "ticker_sentiment_label": "Somewhat-Bearish"}]}, {"title": "What is divestment? And does it work? | Business", "url": "https://www.cnn.com/2024/04/28/investing/stocks-lookahead-divestment-college-protests/index.html", "time_published": "20240428T113000", "authors": ["Nicole Goodkind"], "summary": "What is divestment? And does it work? ...", "banner_image": "https://media.cnn.com/api/v1/images/stellar/prod/240425130717-11-university-campus-protests-unf.jpg?c=16x9&q=w_800,c_fill", "source": "CNN", "category_within_source": "Economy", "source_domain": "www.cnn.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.166667"}, {"topic": "Energy & Transportation", "relevance_score": "0.166667"}, {"topic": "Technology", "relevance_score": "0.166667"}, {"topic": "Economy - Monetary", "relevance_score": "0.990678"}, {"topic": "Economy - Fiscal", "relevance_score": "0.158519"}, {"topic": "Retail & Wholesale", "relevance_score": "0.166667"}, {"topic": "Financial Markets", "relevance_score": "0.929393"}, {"topic": "Manufacturing", "relevance_score": "0.166667"}, {"topic": "Earnings", "relevance_score": "0.682689"}, {"topic": "Real Estate & Construction", "relevance_score": "0.166667"}], "overall_sentiment_score": -0.038818, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "DKNG", "relevance_score": "0.032078", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "PYPL", "relevance_score": "0.032078", "ticker_sentiment_score": "0.124953", "ticker_sentiment_label": "Neutral"}, {"ticker": "MDLZ", "relevance_score": "0.032078", "ticker_sentiment_score": "0.124953", "ticker_sentiment_label": "Neutral"}, {"ticker": "KO", "relevance_score": "0.032078", "ticker_sentiment_score": "0.124953", "ticker_sentiment_label": "Neutral"}, {"ticker": "MDNDF", "relevance_score": "0.032078", "ticker_sentiment_score": "0.124953", "ticker_sentiment_label": "Neutral"}, {"ticker": "COP", "relevance_score": "0.032078", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "NVO", "relevance_score": "0.032078", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "DASH", "relevance_score": "0.032078", "ticker_sentiment_score": "0.102753", "ticker_sentiment_label": "Neutral"}, {"ticker": "PFE", "relevance_score": "0.032078", "ticker_sentiment_score": "0.102753", "ticker_sentiment_label": "Neutral"}, {"ticker": "DPZ", "relevance_score": "0.032078", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "SSNLF", "relevance_score": "0.032078", "ticker_sentiment_score": "0.124953", "ticker_sentiment_label": "Neutral"}, {"ticker": "DMPZF", "relevance_score": "0.032078", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "QSR", "relevance_score": "0.032078", "ticker_sentiment_score": "0.124953", "ticker_sentiment_label": "Neutral"}, {"ticker": "FANG", "relevance_score": "0.032078", "ticker_sentiment_score": "0.124953", "ticker_sentiment_label": "Neutral"}, {"ticker": "MA", "relevance_score": "0.032078", "ticker_sentiment_score": "0.102753", "ticker_sentiment_label": "Neutral"}, {"ticker": "SBUX", "relevance_score": "0.032078", "ticker_sentiment_score": "0.124953", "ticker_sentiment_label": "Neutral"}, {"ticker": "EBAY", "relevance_score": "0.032078", "ticker_sentiment_score": "0.102753", "ticker_sentiment_label": "Neutral"}, {"ticker": "ETSY", "relevance_score": "0.032078", "ticker_sentiment_score": "0.102753", "ticker_sentiment_label": "Neutral"}, {"ticker": "QCOM", "relevance_score": "0.032078", "ticker_sentiment_score": "0.102753", "ticker_sentiment_label": "Neutral"}, {"ticker": "WBD", "relevance_score": "0.032078", "ticker_sentiment_score": "0.02687", "ticker_sentiment_label": "Neutral"}, {"ticker": "CZR", "relevance_score": "0.032078", "ticker_sentiment_score": "0.124953", "ticker_sentiment_label": "Neutral"}, {"ticker": "PINS", "relevance_score": "0.032078", "ticker_sentiment_score": "0.124953", "ticker_sentiment_label": "Neutral"}, {"ticker": "FOREX:EUR", "relevance_score": "0.032078", "ticker_sentiment_score": "-0.153159", "ticker_sentiment_label": "Somewhat-Bearish"}]}, {"title": "3 High-Yield Dividend Stocks That Could Soar 22% to 49%, According to Wall Street", "url": "https://www.fool.com/investing/2024/04/28/3-high-yield-dividend-stocks-that-could-soar-22-to/", "time_published": "20240428T095000", "authors": ["Keith Speights"], "summary": "Whether or not these stocks hit analysts' price targets, they all should be attractive to investors seeking great income and solid growth.", "banner_image": "https://g.foolcdn.com/editorial/images/774353/solar-panels-with-engineers.jpg", "source": "Motley Fool", "category_within_source": "n/a", "source_domain": "www.fool.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.333333"}, {"topic": "Financial Markets", "relevance_score": "0.692272"}, {"topic": "Earnings", "relevance_score": "0.495866"}, {"topic": "Energy & Transportation", "relevance_score": "0.333333"}, {"topic": "Real Estate & Construction", "relevance_score": "0.333333"}], "overall_sentiment_score": 0.33465, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "BEP", "relevance_score": "0.338251", "ticker_sentiment_score": "0.334915", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "BIPC", "relevance_score": "0.468029", "ticker_sentiment_score": "0.413465", "ticker_sentiment_label": "Bullish"}, {"ticker": "BAM", "relevance_score": "0.049835", "ticker_sentiment_score": "0.230288", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "PFE", "relevance_score": "0.338251", "ticker_sentiment_score": "0.146016", "ticker_sentiment_label": "Neutral"}]}, {"title": "3 Dividend Stocks to Buy and Hold for the Next Decade", "url": "https://www.fool.com/investing/2024/04/27/3-dividend-stocks-to-buy-and-hold-for-the-next-dec/", "time_published": "20240427T111500", "authors": ["Keith Speights", "and Prosper Junior Bakiny", "David Jagielski"], "summary": "You'll get dividends and more with these great stocks.", "banner_image": "https://g.foolcdn.com/editorial/images/774374/light-bulbs-with-dollar-sign-person-looking-up.jpg", "source": "Motley Fool", "category_within_source": "n/a", "source_domain": "www.fool.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.5"}, {"topic": "Financial Markets", "relevance_score": "0.998962"}, {"topic": "Earnings", "relevance_score": "0.94762"}, {"topic": "Finance", "relevance_score": "0.5"}], "overall_sentiment_score": 0.273184, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "LLY", "relevance_score": "0.396888", "ticker_sentiment_score": "0.293766", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "ABBV", "relevance_score": "0.360171", "ticker_sentiment_score": "0.156442", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "ABT", "relevance_score": "0.041466", "ticker_sentiment_score": "0.176676", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "FCAP", "relevance_score": "0.041466", "ticker_sentiment_score": "0.086608", "ticker_sentiment_label": "Neutral"}, {"ticker": "PFE", "relevance_score": "0.284106", "ticker_sentiment_score": "0.173062", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "Jim Cramer Weighs In Ahead Of Apple, Amazon, Eli Lilly Earnings: 'We Have To Run Such A Ridiculous Gauntlet Next Week' - Apple  ( NASDAQ:AAPL ) , Amazon.com  ( NASDAQ:AMZN ) ", "url": "https://www.benzinga.com/general/market-summary/24/04/38474759/jim-cramer-weighs-in-ahead-of-apple-amazon-eli-lilly-earnings-we-have-to-run-such-a-ridicu", "time_published": "20240427T023316", "authors": ["Ananya Gairola"], "summary": "Jim Cramer, the host of CNBC's \"Mad Money,\" has outlined the key events that investors should keep an eye on in the upcoming week. What Happened: Cramer highlighted the significant events scheduled for the week, including earnings reports from Apple Inc. AAPL, Amazon.com Inc.", "banner_image": "https://cdn.benzinga.com/files/images/story/2024/04/26/Photo-Courtesy-of-Scott-Beale-on-Flickr.jpeg?width=1200&height=800&fit=crop", "source": "Benzinga", "category_within_source": "News", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.25"}, {"topic": "Technology", "relevance_score": "0.25"}, {"topic": "Economy - Monetary", "relevance_score": "0.310843"}, {"topic": "Retail & Wholesale", "relevance_score": "0.25"}, {"topic": "Financial Markets", "relevance_score": "0.108179"}, {"topic": "Manufacturing", "relevance_score": "0.25"}, {"topic": "Earnings", "relevance_score": "0.451494"}], "overall_sentiment_score": 0.074813, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "CVS", "relevance_score": "0.096671", "ticker_sentiment_score": "0.056746", "ticker_sentiment_label": "Neutral"}, {"ticker": "GOOG", "relevance_score": "0.191929", "ticker_sentiment_score": "-0.004983", "ticker_sentiment_label": "Neutral"}, {"ticker": "NVDA", "relevance_score": "0.096671", "ticker_sentiment_score": "0.138544", "ticker_sentiment_label": "Neutral"}, {"ticker": "AAPL", "relevance_score": "0.28442", "ticker_sentiment_score": "0.211366", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "WING", "relevance_score": "0.096671", "ticker_sentiment_score": "0.056746", "ticker_sentiment_label": "Neutral"}, {"ticker": "MDNDF", "relevance_score": "0.096671", "ticker_sentiment_score": "0.056746", "ticker_sentiment_label": "Neutral"}, {"ticker": "PFE", "relevance_score": "0.096671", "ticker_sentiment_score": "0.056746", "ticker_sentiment_label": "Neutral"}, {"ticker": "DPZ", "relevance_score": "0.096671", "ticker_sentiment_score": "0.056746", "ticker_sentiment_label": "Neutral"}, {"ticker": "MSFT", "relevance_score": "0.191929", "ticker_sentiment_score": "-0.004983", "ticker_sentiment_label": "Neutral"}, {"ticker": "DMPZF", "relevance_score": "0.096671", "ticker_sentiment_score": "0.056746", "ticker_sentiment_label": "Neutral"}, {"ticker": "TSLA", "relevance_score": "0.096671", "ticker_sentiment_score": "-0.176479", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "SBUX", "relevance_score": "0.096671", "ticker_sentiment_score": "0.056746", "ticker_sentiment_label": "Neutral"}, {"ticker": "LLY", "relevance_score": "0.28442", "ticker_sentiment_score": "0.116715", "ticker_sentiment_label": "Neutral"}, {"ticker": "AMZN", "relevance_score": "0.191929", "ticker_sentiment_score": "0.085316", "ticker_sentiment_label": "Neutral"}, {"ticker": "BA", "relevance_score": "0.096671", "ticker_sentiment_score": "-0.176479", "ticker_sentiment_label": "Somewhat-Bearish"}]}, {"title": "Cramer's week ahead: Fed meeting and earnings from Apple, Amazon, Eli Lilly", "url": "https://www.cnbc.com/2024/04/26/cramers-week-ahead-fed-meeting-and-apple-amazon-eli-lilly-report.html", "time_published": "20240426T222814", "authors": ["Julie Coleman"], "summary": "CNBC's Jim Cramer on Friday walked investors through next week on Wall Street.", "banner_image": "https://image.cnbcfm.com/api/v1/image/107407217-1714171689MM-A-042624-short.jpg?v=1714171688&w=750&h=422&vtcrop=y", "source": "CNBC", "category_within_source": "Top News", "source_domain": "www.cnbc.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.2"}, {"topic": "Technology", "relevance_score": "0.2"}, {"topic": "Finance", "relevance_score": "0.2"}, {"topic": "Economy - Monetary", "relevance_score": "0.310843"}, {"topic": "Retail & Wholesale", "relevance_score": "0.2"}, {"topic": "Financial Markets", "relevance_score": "0.839681"}, {"topic": "Manufacturing", "relevance_score": "0.2"}, {"topic": "Earnings", "relevance_score": "0.310843"}], "overall_sentiment_score": 0.147279, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "MSFT", "relevance_score": "0.067727", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "CVS", "relevance_score": "0.067727", "ticker_sentiment_score": "0.027047", "ticker_sentiment_label": "Neutral"}, {"ticker": "META", "relevance_score": "0.134968", "ticker_sentiment_score": "0.003766", "ticker_sentiment_label": "Neutral"}, {"ticker": "NVDA", "relevance_score": "0.329112", "ticker_sentiment_score": "0.265199", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "WING", "relevance_score": "0.067727", "ticker_sentiment_score": "0.027047", "ticker_sentiment_label": "Neutral"}, {"ticker": "BAC", "relevance_score": "0.067727", "ticker_sentiment_score": "-0.081196", "ticker_sentiment_label": "Neutral"}, {"ticker": "MDNDF", "relevance_score": "0.067727", "ticker_sentiment_score": "0.12426", "ticker_sentiment_label": "Neutral"}, {"ticker": "SBUX", "relevance_score": "0.201244", "ticker_sentiment_score": "0.320868", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "MS", "relevance_score": "0.067727", "ticker_sentiment_score": "0.052148", "ticker_sentiment_label": "Neutral"}, {"ticker": "WDC", "relevance_score": "0.067727", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "PFE", "relevance_score": "0.067727", "ticker_sentiment_score": "0.027047", "ticker_sentiment_label": "Neutral"}]}, {"title": "Apple, Amazon, Big Pharma And The Fed: Investing Action Plan", "url": "https://www.investors.com/research/investing-action-plan/stock-market-apple-amazon-big-pharma-the-fed/", "time_published": "20240426T221700", "authors": ["ALAN R. ELLIOTT", "Investor's Business Daily"], "summary": "A Big Week For The Stock Market: Apple, Amazon, Big Pharma And The Fed Investor's Business Daily ...", "banner_image": "https://www.investors.com/wp-content/uploads/2024/01/Stock-FedBldg-flag-adobe.jpg", "source": "Investors Business Daily", "category_within_source": "n/a", "source_domain": "www.investors.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.2"}, {"topic": "Energy & Transportation", "relevance_score": "0.2"}, {"topic": "Technology", "relevance_score": "0.2"}, {"topic": "Blockchain", "relevance_score": "0.158519"}, {"topic": "Economy - Monetary", "relevance_score": "0.158519"}, {"topic": "Retail & Wholesale", "relevance_score": "0.2"}, {"topic": "Financial Markets", "relevance_score": "0.999606"}, {"topic": "Manufacturing", "relevance_score": "0.2"}, {"topic": "Earnings", "relevance_score": "1.0"}], "overall_sentiment_score": 0.189522, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "AAPL", "relevance_score": "0.270149", "ticker_sentiment_score": "0.056371", "ticker_sentiment_label": "Neutral"}, {"ticker": "MDNDF", "relevance_score": "0.03443", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "NVO", "relevance_score": "0.068797", "ticker_sentiment_score": "0.040372", "ticker_sentiment_label": "Neutral"}, {"ticker": "DDOG", "relevance_score": "0.103035", "ticker_sentiment_score": "0.122123", "ticker_sentiment_label": "Neutral"}, {"ticker": "AWON", "relevance_score": "0.03443", "ticker_sentiment_score": "0.151018", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "AMGN", "relevance_score": "0.170878", "ticker_sentiment_score": "0.032061", "ticker_sentiment_label": "Neutral"}, {"ticker": "PFE", "relevance_score": "0.170878", "ticker_sentiment_score": "0.043458", "ticker_sentiment_label": "Neutral"}, {"ticker": "DPZ", "relevance_score": "0.068797", "ticker_sentiment_score": "0.326415", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "MA", "relevance_score": "0.03443", "ticker_sentiment_score": "0.10474", "ticker_sentiment_label": "Neutral"}, {"ticker": "SBUX", "relevance_score": "0.068797", "ticker_sentiment_score": "0.104639", "ticker_sentiment_label": "Neutral"}, {"ticker": "AMD", "relevance_score": "0.103035", "ticker_sentiment_score": "0.123387", "ticker_sentiment_label": "Neutral"}, {"ticker": "LLY", "relevance_score": "0.103035", "ticker_sentiment_score": "0.043751", "ticker_sentiment_label": "Neutral"}, {"ticker": "DELL", "relevance_score": "0.068797", "ticker_sentiment_score": "0.113638", "ticker_sentiment_label": "Neutral"}, {"ticker": "SQ", "relevance_score": "0.068797", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "PYPL", "relevance_score": "0.137083", "ticker_sentiment_score": "0.109307", "ticker_sentiment_label": "Neutral"}, {"ticker": "META", "relevance_score": "0.068797", "ticker_sentiment_score": "0.067624", "ticker_sentiment_label": "Neutral"}, {"ticker": "NVDA", "relevance_score": "0.103035", "ticker_sentiment_score": "0.122123", "ticker_sentiment_label": "Neutral"}, {"ticker": "KO", "relevance_score": "0.103035", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "SMCI", "relevance_score": "0.068797", "ticker_sentiment_score": "0.044114", "ticker_sentiment_label": "Neutral"}, {"ticker": "CCJ", "relevance_score": "0.103035", "ticker_sentiment_score": "0.122123", "ticker_sentiment_label": "Neutral"}, {"ticker": "DMPZF", "relevance_score": "0.03443", "ticker_sentiment_score": "0.316853", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "EBAY", "relevance_score": "0.137083", "ticker_sentiment_score": "0.109307", "ticker_sentiment_label": "Neutral"}, {"ticker": "ETSY", "relevance_score": "0.103035", "ticker_sentiment_score": "0.096925", "ticker_sentiment_label": "Neutral"}, {"ticker": "AMZN", "relevance_score": "0.103035", "ticker_sentiment_score": "0.049741", "ticker_sentiment_label": "Neutral"}, {"ticker": "WMT", "relevance_score": "0.103035", "ticker_sentiment_score": "0.122123", "ticker_sentiment_label": "Neutral"}, {"ticker": "CRYPTO:BTC", "relevance_score": "0.03443", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}]}, {"title": "COVID-19 Patent Dispute Sorted: Acuitas Therapeutics and CureVac Reach Settlement In Patent Battle - CureVac  ( NASDAQ:CVAC ) ", "url": "https://www.benzinga.com/general/biotech/24/04/38468361/covid-19-patent-dispute-sorted-acuitas-therapeutics-and-curevac-reach-settlement-in-patent-battle", "time_published": "20240426T184500", "authors": ["Vandana Singh"], "summary": "Canadian Biotech company Acuitas Therapeutics and Germany-based CureVac NV CVAC have settled Acuitas' lawsuit over credit for inventions tied to COVID-19 vaccines. In November 2023, Acuitas Therapeutics filed a lawsuit in Virginia federal court against CureVac, accusing it of failing to credit ...", "banner_image": "https://cdn.benzinga.com/files/images/story/2024/04/26/covid-vaccine-shutter.jpeg?width=1200&height=800&fit=crop", "source": "Benzinga", "category_within_source": "General", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}], "overall_sentiment_score": -0.031587, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "GSK", "relevance_score": "0.191929", "ticker_sentiment_score": "-0.289675", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "PFE", "relevance_score": "0.604787", "ticker_sentiment_score": "-0.194623", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "BNTX", "relevance_score": "0.66878", "ticker_sentiment_score": "-0.157131", "ticker_sentiment_label": "Somewhat-Bearish"}]}, {"title": "FDA Green Lights Pfizer's Gene Therapy For Rare Bleeding Disorder Hemophilia - Pfizer  ( NYSE:PFE ) ", "url": "https://www.benzinga.com/general/biotech/24/04/38468053/fda-green-lights-pfizers-gene-therapy-for-rare-bleeding-disorder-hemophilia", "time_published": "20240426T183008", "authors": ["Vandana Singh"], "summary": "Friday, the FDA approved Pfizer Inc's PFE Beqvez ( fidanacogene elaparvovec-dzkt ) for moderate to severe hemophilia B in adult patients who currently use factor IX ( FIX ) prophylaxis therapy or have current or historical life-threatening hemorrhage, or have repeated, serious spontaneous ...", "banner_image": "https://cdn.benzinga.com/files/images/story/2024/04/26/Pfizer-shutterstock2.jpeg?width=1200&height=800&fit=crop", "source": "Benzinga", "category_within_source": "General", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}], "overall_sentiment_score": 0.0, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "PFE", "relevance_score": "0.570165", "ticker_sentiment_score": "-0.042032", "ticker_sentiment_label": "Neutral"}]}, {"title": "Pharma Stock Roundup: MRK, SNY, AZN, NVS' Q1 Results, Pipeline & Regulatory Updates", "url": "https://www.zacks.com/stock/news/2263464/pharma-stock-roundup-mrk-sny-azn-nvs-q1-results-pipeline-regulatory-updates", "time_published": "20240426T153400", "authors": ["Kinjel Shah"], "summary": "Merck (MRK), Sanofi (SNY), Novartis (NVS) and AstraZeneca (AZN) announce their first-quarter results.", "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/96/702.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Earnings", "relevance_score": "0.999953"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.214378"}], "overall_sentiment_score": 0.158632, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "LLY", "relevance_score": "0.104835", "ticker_sentiment_score": "0.014231", "ticker_sentiment_label": "Neutral"}, {"ticker": "AZN", "relevance_score": "0.207868", "ticker_sentiment_score": "0.026596", "ticker_sentiment_label": "Neutral"}, {"ticker": "NVO", "relevance_score": "0.070002", "ticker_sentiment_score": "-0.068262", "ticker_sentiment_label": "Neutral"}, {"ticker": "PFE", "relevance_score": "0.070002", "ticker_sentiment_score": "-0.068262", "ticker_sentiment_label": "Neutral"}, {"ticker": "SNY", "relevance_score": "0.139467", "ticker_sentiment_score": "0.024867", "ticker_sentiment_label": "Neutral"}]}]}